comparing them, if you look at the chart of lilly versus nvo, nvo is vertical, where lilly looks likest breaking out. i'd be more comfortable being there. generally speaking i agree with karen. there's been a run, but potentially massive long-term. >> yeah. courtney >> i think people got excited about this pace last year and turned on it this year after it that massive outperformance. you're starting to see people come back into the space, but i think that's likely going to continue this year yes, it's had a good run, but still has room definitely want this in your portfolio. >> is this in your barbell either end >> merck you look at the earnings, 70 times for america, 40 and 8 time lilly. looking at divergent -- you've got the celebrity endorsements i always think that's going to attract the retail investor. >> time for the final trade. let's go around the horn jeff mills. >> well, we've all said it -- merck. i think generally throws into health care have been week, so i'm watching the 115 level i think it breaks and goes higher. >> bonawyn eison >> staying calm with mcdonald's. >> e

will eli lilly help cover that cost?ant to understand how complex the issue is about access. we're committed to getting access to the -- for the people that need i had. that is going to require all of us to work together. obesity is the largest disease epic we have in society today and probably in the history of i will necessaries. we're working with several organizations to come together as a government, as a society to really figure out how are we going to get the therapy that's are being innovated to day to the right people that need them around the world? and we're committed to that and a lot of efforts in that space. >> help us understand what that means. there will be lobbying to get it covered by medicare, for example, medicaid. but you guys stand to make a ton of money on this. and the thought it may be only accessible by the richest folks i think is troubling to some people. are there steps that eli lilly would take to lower the cost for those that don't have that much money? >> i think, again, we are, obesity e

we have lilly.ing hoims elizabeth holmes was due to report to prison today that has been delayed. >>> and we will speak with bobby kotick after the regulator blocked the deal for activision-blizzard. what's next? we'll answer that at 8:00 a.m. don't go anywhere. "squawk box" is coming right back >> announcer: currency check is sponsored by interactive brokers. best informed brokers choose interactive brokers. >>> welcome back something good must have happened since the beginning of the show up 190 points on the dow a lot of dow reporting that is being well received for some of these names. you have it. that is helping. caterpillar is helping more than any with the 7 point gain. caterpillar and honeywell and merck trading higher >>> elizabeth holmes will not go to prison despite the order to serve the 11--year sentence today. on tuesday, elizabeth holmes' ton attorneys appealed to the t appeals court. holmes will remain free on bail for now. the government has ten days to respond. holmes was convicte

and we talked about lilly relative to an nvo lilly's chart looks better, kind of just breaking out tohighs versus nvo that's run a little bit already so, there's room to go here. >> the all-time high bother you -- >> yeah. i -- listen, i don't love buying a breakout like this, okay because it's gone from, what, $315 just about a month and a half ago, to where it is right now at 390, and if you just look at that chart that jeff is talking about from late 2020, it has held that uptrend like a boss but it's giving you lots of opportunities to buy it back at that uptrend and this drug really is going to have all of those characte characteristics, higher than 22% of employees, that's going to be a theme that you're going to play for years so, buying it here up 22% in six weeks is probably not the best way to enter a position in this. >> at the same time, some of the other drug makers that are not doing very well, merck came out with results they're okay pfizer is not doing well stock-wise and so, is there sort of, like, a trade where you think, oh, i don't want to be in these drug makers,

>> i am just wondering about eli lilly. is this a goodbye level? eli lilly did get a high this week. we wanted to come in. it is starting to come down a little bit. i don't see any reason why you have to pay 374. he may get this one at 360. >> how about we go to ian in illinois. ian? >> hey, jimmy. how are you doing? happy friday. >> i am ready for friday. i am trying to see if i can do some work tonight but my wife insists on going out. >> i think you should join her. you deserve some fun. >> my friends made fun of me about this last year but i doubled already after they recently updated guidance and it was better than expected. they gave a positive report on franchise growth. i see this one is the chipotle of sandwiches. do i have a long-term winner with potbelly? i cannot believe this. these sandwiches are great. i mentioned the calories. they are really good. you are right. this is a nine dollar stock. potbelly is just tasty. it is the only sandwich i eat otherwise, i eat a salad. wall street is awfully negative heading into the season which co

then lillian lilly trained once or twice away her and that makes a difference in dover dust mother. so he does not want a sheet map and her dad used to be a skateboarder himself. he 1st had lily on a board at the tender age of 12 months. oliver started coaching her when she was 5 1st once a week and then progressively more until her appearance at the 2020 olympics, which most people at her school know about personal time. the houses are sometimes they ask about how she or i feel during the competitions and our ha, but i don't find it annoying. now rule as mentioned, you know, some teachers might know because the reading the news. but your average pupil has no idea who i am and there's a similar lack of fast when it comes to training preparations with her father. instead of rigid rules, the focus is more on creative freedom in humor, lee, no. i normally have a plan for which will occur to me when i go to bed. and while i'm sleeping alpha for yeah, i know the, you know, the, i'll think of this or that trick that we can do and was in for this. i mean, it's not as if we have no plan thi

have pfizer, amgen, other companies with earlier assets, but novo and lilly are in phase three.novo thinks its next drug result in a 25% weight loss. the market dynamics right now have these two guys in a big head start. >> can i ask you about m & a in the sector they obviously spun off novo nordisk, san detdos, the generic business is there more to come? >> one question we get asked a lot is could we see the other companies we cover with consumer health businesses which are buyeb beyer and sanofi neither has anything to do with consumer business today. on the m & a side it seems like since biotech has reset in the u.s., we're waiting for a flurry of details which hasn't ma mater materialized a lot of companies, roche, novartis, sanofi, they've expressed bold times, small deals, don't expect anything bigger transformative. we're going to keep asking on the calls. >> thank you, emily, for doing that for us. also when you think about the context of how big the market can grow, they tackle that issue. emily field, thank you. >>> now, u.s. verification that ventilation company carri

. >> lilly listed wells. joe, you own lilly >> both lilly and merck have maintained positive momentum where health care has been a relative performer going back to unh, that's when it peaked. the market actually found its bottom eli lilly and america are two areas of health care that have displayed a degree of strong resiliency and that should give you confidence as an investor where you want to be >> bryn, health care like it, yes or no >> absolutely. health care was my sector pick going into this year once again i go back to keep it simple going into a contraction of sorts you do want to overweight health care staples and utilities. i felt coming into the year they were overvalued but health care gives you that pharma biotech that growth, it gives you free cash flow yield. as we continue to see the data come in and as the economy continues to weaken, health care will be that safe spot if you want free cash flow and growth, so many individual companies to go into within health care starting right now >> okay

what does the data that eli lilly is putting out there say? preface this by saying this is straight from a press release from eli lilly, not published in a medical journal, no one's reviewed it, so take it for what it is. in this study, over 900 people who have type ii diabetes and were either overweight or obese, average weight they started at 222 pounds. these were people that were quite heavy. and over the course of the 22-month study, they lost 34 pounds. that is a big weight loss. you don't usually see that level of weight loss with a weight loss drug. but it may come at a certain price. what they found is that one in five people suffered from nausea or diarrhea. that's a lot, one in five, nausea or diarrhea. and also, a fair number of people had vomiting and constipation. i don't mean to get so graphic, but it certainly raises the question of whether people will be willing to take this drug if they're going to feel that way. and it actually gets even more severe. more unusual. they did warn, the company says that there may be side effect

lilly in pleasanton needed help with a travel agency, too.ly paid them $596 for theme park tickets and then the pandemic happened. recently lilly wanted to use those tickets but wound up in a tug of war between the agent and theme park. she asked us to help, the travel agency then gave lilly the refund. go ahead our board. since we started back in 2016, nbc bay area responds and telemundo responde have helped viewers like you get back almost $7 million. share your story with us, scan the qr code on your screen right now to fill out our consumer complaint form online. >>> good morning. i'm thom jensen. coming up in a live report, the latest in a fatal shooting that left a 5-year-old santa clara girl dead and the possible connection to three people now in custody. >>> right now at 5:30, a family left grieving, after their 50-year-old daughter becomes the latest victim of a freeway shooting. ahead, we're learning about the people police have in custody, as violence on bay area highways once again comes into focus. >> plus, stanford easing covid

because of eli lilly. eli lilly is not a one trick pony. they are also working on a revolutionary alzheimer's drug which we heard today could pop the stock by 10% but now, lily is i'll be back to 362. we are only on day two of a rotation in the safety stocks. they usually last three or four days, then rest. i think that will happen again. it is one of my favorites for all of 2003, procter & gamble. this year, procter & gamble got three big breaks, transportation b,, royal greens plummeted, and the dollar stopped going higher. yet, what did the stock do? despite all these positives, the stock got by slam, because of rotation. now, with the treasury at a multi-month low, being less competition for the 2.4% yield, there is grudging recognition that this stock is too cheap. sure, $131 with lows of 136, but we haven't heard a peep out of the single saying good things. i think proctor goes higher, maybe not much higher. its costs are coming down. but in going to cut the price to you at the supermarket. what do these have in common? how about the

lilly paid them $596 for four theme park tickets. then the pandemic happened.ently lilly wanted to use those tickets but wound up in a tug of war between the agent and theme park. she asked us to help. the travel agency then gave lilly a full $596 refund. we haven't charted out our board in a board. since we started in 2016, nbc bay area responds and telemundo responde have helped viewers like you get back almost $7 million. share your story. scan the qr code on your screen to fill out our complaint form online. >> thanks, chris. >>> it's a busy morning at "today in the bay." next, the top stories we're following today, including a sinkhole opening up overnight in the east bay. the warning from police this morning. >> reporter: and i'm thom jensen. coming up in a live report, the latest on that tragic freeway shooting that left a 5-year-old santa clara girl dead, and why the arrest of three people in the arrest of three people in santa cruz could be conneed toct our cucustomers dodon't do what thehey do for likes s or followewers. their papath isn't for ththe c

. >> reporter: it's being billed by eli lilly as a new bar for weight loss. >> i'm very pleased with the results >> reporter: called tirzepatide. currenently sold undnder the brbrand name monjaro. to treat type 2 diabetes if approved for weight loss, analysts believe it could be the biggest drug ever. >> we're bringing on more manufacturing capacity and throughout this year to help make sur we're able to meet demand in the marketplace. >> reporter: a clinical trial last year found the dru helped people with obesity lose almost a quarter of their body weight today the company announced new results of a second clinical trial, which followed more than 900 adults with both obesity and type 2 diabetes. finding patients lost up to 15.7% of body weight in about 16 months >> weight loss is hard for patients with diabetes and i think in america we have a lot of stigma about, hey, you need to be able to do this on your own. >> reporter: tirzepatide works similarly to drugs like ozempic and wegovy also shown to cause weight loss. the difference it combines two medications together >> the summar

tonight, patients who took eli lilly's weight loss, drug tours, appetite. >> lost on average up to 34or 16% of their body weight over about 17 months. the company said in a clinical trial results that was released today. eli lilly says it plans to complete its application for fda approval of the drug in the coming weeks and expects regulatory action as early as later this year. the fda did approve appetite for type 2 diabetes last year, but the drug is not cleared yet for weight loss. still ahead at 6 wnba star brittney griner talking publicly about her imprisonment in russia for the first time. >> what made her shed tears during her news us the man accused of assaulting a former san francisco fire commissioner with a metal pipe is released from custody. >> kron four's legal analyst michael cardoza is here to join us in the studio to weigh in on the judge's decision. >> our top story tonight. at 6.30, the man accused of hitting former san francisco fire department commissioner don carmignani with a metal pipe earlier this month was released from custody today. this development came do

drugmaker eli lilly said today one of its medications used to treat type 2 diebds has shown promisingesults when it comes to weight loss, and it's asking the fda for fast track approval. cbs's nikki battiste says it could become the most effective treatment for those looking to lose weight. >> people taking monday jar row lost up to 25 pounds. >> reporter: it's the newest drug causing a frenzy, and the drugmaker says it's the most effective for weight loss yet. >> i asked my doctor specifically for mounjaro. >> reporter: in august, rachel graham's doctor told her she was about 65 pounds overweight and pre-die gettic. she was prescribed moun jar row. >> the weight loss was slow and steady. two and three pounds a week consistently until i had lost 65 pounds. >> reporter: in a late-stage trial, eli lilly says overweight patients with diabetes lost up to 16% of their body weight. in an earlier trial, overweight patients without diabetes lost up to 22.5% of their body weight. >> mounjaro affects two hormone receptors that affect appetite and satiety. so it turns out the combination works a

to or 3 pounds a week specifically until i had lost 6. >> reporter: in a late stage trial, eli lillyiabetes lost up to 16% of their body weight. in an earlier trial, overweight patients without diabetes lost up to 22.5% of their body weight. >> mounjaro affect two hormone receptors that affect appetite. it turns out the combination works a little bit better. >> reporter: those using two other popular drugs for weight loss, ozempic and we go be, lost up to 15% of their body weight. social media has increased the demand in the number of prescriptions is soaring. >> people are coming and asking for the medication by name. >> reporter: common side effect include nausea, vomiting, and diarrhea, some have reported hair loss on the medication needs to be taken long term. speak with the medicine is stopped, there is a very good chance that weight will be regained. >> reporter: mounjaro cost about $1,000 a month, and it is not covered by most insurance. nikki battiste, cbs news, new york. >> norah: tonight, we continue our look at crime in america, with a focus on illegal guns. there is new d

drugmaker eli lilly today said one of its medications used to treat type 2 diabetes has shown promisingt is asking the fda for a fast-track approval. cbs's nikki battiste reports in tonight's "health watch," it could become the most effective treatment for those looking to lose weight. >> people taking mounjaro lost up to 25 pounds. >> reporter: it is the newest drug causing a frenzy, and the drugmaker says it is the most effective for weight loss yet. >> i asked my doctor specifically for mounjaro. >> reporter: in august, rachel graham's doctor told her she was about 65 pounds overweight and prediabetic. she was prescribed mounjaro. >> the weight loss was slow and steady. 2 or 3 pounds a week consistently until i had lost 65 pounds. >> reporter: in a late-stage trial, eli lilly says overweight patients with diabetes lost up to 16% of their body weight. in an earlier trial, overweight patients without diabetes lost up to 22.5% of their body weight. >> mounjaro affect two hormone receptors that affect appetite and satiety. it turns out the combination works a little bit better. >> report

. >> reporter: it's being build by eli lilly as a new bar for weightht loss. >> i'm v very pleased withoss. >> reporter: called terz tide. >> more capacity throughout this year to help to make sure we're able to meet the demand. >> reporter: a clinical trial found it helped people with obesity lose almost a quarter of their body weight. today the company announced new results of a second clinical trial, which followed more than 900 adults with both obesity and type 2 diabetes. patients lost up to 15.7% of body weight in about 16 months. >> weight loss is hard for patients with diabetes. and i think in america we have a lot of stigma about hey, you need to be able to do this on your own. >> reporter: it works similarly to drugs like ozempic and wegovy. the medication combines two medications together. >> the summary effect is that it helps your stomach feel full sooner. >> reporter: forealmost a year jennifer huber has been taking the drug once a week to treat her type 2 diabetes. >> i get emotional. i'm down about 60 pounds, which that was not part of the plan. >> reporter: did this dru

it's not just tech how about eli lilly? today lilly talked about how they're about to ask the fda for approval to sell their diabetes drug as a weight loss pill based on -- go like that based on the data we have, we hope it's going to be the pill one day. based on the data we have it could be a game changer. it's looking like get this, this is what this thing does. not only does it lower -- is it good for diabetes and lowers weight, it lowers cholesterol, it lowers blood pressure, and here's a new one it can cut out heavy drinking. and heavy drinking's just plain bad for you. much as it pains me to say that since my wife owns a mezcal company. >> the house of pain >> jumped 14 bucks today it's been a horse. genuine secretariat. it's run from 312 to 390 in less than two months because we don't have enough good news on the fda approval yet i do think it can run and run and run some more. there are a lot of good drug stocks out there but lilly is the standout how about chipotle caught in the scrum between cheesecake factory an

according to a study from drugmaker eli lilly, a new diabetes medication under the name of mounjaro ising us now with more is dr. kavita patel, former white house policy director for the obama administration, also an msnbc medical contributor. always a pleasure to see you. what are the conversations you're having with patients about these new drugs? >> these drugs a game changer and truly a life saver for my diabetic patients. that has been the original indication that all the drugs including mounjaro have the fda approval for. there is a weight losspp ozempic. that is on the market. these are majority of the united states adult diabetics have this particular type of diabetes, and i am seeing not just dramatic improvements in their glucose control, they come off of insulin, they come off all their other medications, but they also had this weight loss, which is why lilly has done this trial and shown that they can have over 900 adults this is what is staggering, a 15% body weight loss and that's just something that, you know, we haven't seen in this field, it is changing the dynamics ar

and there are accounts with lilly is known for her stealing of her. the trials and tribulations don't seem to get to her except then a brief but faithful lapse of concentration. ah, perhaps it was all a bit too much for the youngster with the might of tea. my teammates were all in hospital after getting injured, so the mood was a bit down and i was already sick anyway and got slammed on the day of the contest . i saw there were a lot of factors against me and i had to put in my absolute safety run woman up. so still finishing intent was way more than i imagined with deemed seen. and so this was he wants to conduct center and there weren't any qualification points on the line this time anyway. although for lily, it's not just about the olympics language. i'm not aiming for one particular contest. mr. qantas as a sure the olympics are probably the biggest thing out there. and so does all of that. i just want to carry on skating well together with my friends going from contest to contest and maybe some day turning pro pro skater bad on fine, perhaps priz

this is where my mother's grave was mrs. wake up ali lilly mccoy livingston. alexander buried her here in his guard, only after the russians retreated, could he move her to a cemetery? and yet, alexander doesn't want to be of was rochelle new thee, i believe that people have experienced such horror that it is difficult for me to add anything. yeah, you have to live, we want to live open you and panic. little there's no sense in panicking like when you where to run could that we have nowhere to run to? liberty. we'll see what happens. i shall go lip. i'll budge him. most of those who are still here, feel like him. every one we met, you can talk about pain and loss, but it seems courage and determination run just as deep ah, for homeless and destitute migrant workers in india's capital, deli cold winter nights are especially trying. one organization is helping with food and shelter. it's early morning on a frigid day in daily and scores of people have lined up for up up of what d and breakfast for most of them, it may be the only decent wheel they'll have to do. this is just one of the l

in rehearsed lilly i visited on 18 children's gray silent while at adobe k. been mystic. you should have been going on for deep breath, were able to rescue some of the girls members, including a 15 year old girl. they have been transferred to hospital some out in critical condition. wilton, her bottom toward the work was and i'm glad we found one child to day soccer up on an urge that more effort goes into searching was expensive, a real laconically. oh that will find more children. apollo. and now your queen, queen, by what little wing ye will be found, not books and religious. medea in some of the abandoned tombs boil mackenzie, the leader of the good news. international church, if believed to have encouraged his followers to stop them 1st to death with the promise of meeting jesus in the after life. he was arrested last week after police discovered the border of fort church members. as the search operation continues, beliefs fear they will discover even more bodies. let's have a look now. some of the other stories making news around the world. thousands of protesters h

skate is rated by speed, creativity, the difficulty delivery an range of tricks and that era counts. lilly is known for her stealing nerves. oh, the trials and tribulations don't seem to get to her. except then a brief but faithful lapse of concentration. ah, perhaps it was all a bit too much for the youngster with the might of tea. my teammates were all in hospital after getting injured, so the mood was a bit down and who was already sick anyway and got slammed on the day of the contents. i saw there were a lot of factors against me and i had to put in my absolute safety rotten woman up . so still finishing and 10th was way more than i imagined. redeemed seemed so bad associates gesenta and there weren't any qualification points on the line. this time anyway, although for lily it's not just about the impacts language. i'm not aiming for one particular contest. the student that called to us as the sure the olympics are probably the biggest thing i was there. and so does all of that. i just went to carry on skating well together with my friends going from contest to contest and maybe some d

lilly is a long-term good holding in the portfolio we would add lilly or gilead. >> victoria, we arefunds flow survey they are saying they saw the first u.s. equity inflows in weeks along with corporates for stock buybacks tech led inflows which is true year to date and the first inflows in financials in four weeks. technology is that some place you want to be is there an opportunistic area in technology overall? i ask because there are a lot of tech earnings coming out this week >> you are right a busy week for tech if we are going in the tech space, we are not going for the high flying faang names with massive run-ups this year. we will look at the names like ibm or cisco i think you can find tech names that have more growth opportunities associated with them from where they currently sit versus nvidia. i would look more profitable >> victoria fernandez. thank you. see you soon >>> that's today it for us on "worldwide exchange." quk x"s mi unext see you tomorrow rebecca who e c ♪ ♪ and this is fernando, ♪ ♪ searching savings with a click. ♪ online or in-store, for your health and y

pfizer yields 4% i would suggest you -- lilly reports next week. recommend them into the report. j&j has a 3% yield it has a couple of things going on with talc that's not positive i prefer j&j to pfizer after going through some of the top performing health care ipos in 2021, there are genuine winners. nice additions to the s speculative portion of your ipo. we have bonus ipos that fall into miscellaneous. >>> is slowdown something investors should be worried about. the i'm sharing the clues we've gotten all of your calls, rapid fire in tonight's edition of the lightning round so stay with cramer ♪ ♪ the biggest ideas inspire new ones. 30 years ago, state street created an etf that inspired the world to invest differently. it still does. what can you do with spy? ♪ ♪ what do you get from the morgan stanley client experience? listening more than talking, and a personalized plan ♪ to guide you through a changing world. ♪ ♪♪ the only thing i regret about my life is that i did what everyone else did at the time. i hired local talent. if i knew about up

happy earthquake day and you want to do some singing let's hear it for lilly anyone remember the words of san francisco oh, you haven't? >> i'm going to give you $1 million. thank you very much. >> (laughter.) >> by tommy dorsey. >> this is in the 30s all right. >> (clearing throat) you know the beginning. >> and everybody up here willie come on up. >> and i want to thank you, who did this it is, you know, fshl legal ready. >> are you kidnapping (laughter). >> all right. everyone has to join in now it only takes a corner this great big world to find a place we love my home that on a hill you, you know, you love you still i've been away but now about to tell you san francisco open your golden gates we'll make a way out our donor. >> san francisco here is you're wondering one paying the wonder no more. >> other places only make me love you best and tell me you're the hardest one the goldberg west. san francisco (laughter). >> we are coming home to stop wondering no more. >> yeah. >> nicely done. >> (clapping) did you sing that in full voice somehow that was in full voice thank you for be

, somebody pretend to go be eli lilly, made a major announcement and the company's stock plunged.an no longer trust what is on twitter is the person representing or proclaiming to represent. >> and we can't find how much money they're really garnering because the communications department. >> here is the other thing. a lot of people who still have a blue check for some reason are asking it be removed because they're embarrassed. >> it looks like they paid. >> correct. >> interesting. so it's now the opposite. not having a blue check is cool. >> so many people wanted one. >> no blue checks here this morning. >>> let's check in with meteorologist kari hall right now. she is tracking more of what is expected in our upcoming fire season as we talk about earth week. >> yes, it's our climate in crisis series we continue, especially this earth week. wildfires are becoming more frequent and scorching more land as temperatures warm. the outlook for this upcoming season is expected to be average, despite all of the rain we've had. but the number of hands trained to tame those flames is ofte

lilly announced the 70% reduction in insulin. that's a start. but the american people, believe me, whether you're republican, democrat, independent whatever you are, conservative or progressive, they are sick and tired of getting off by the pharmaceutical industry. we're going to deal with that. we're going to with raising the minimum wage to a living wage. we are the only major country on earth not to guarantee health to all. i believe that we should toward a medicare for all single payer program. i don't have the votes to do that. i no republican support for that. half the democrats don't support it. but at least what i want to do is expand community health centers so we can make primary health care available to all americans at a cost that's affordable. this is your what, 7 to 8 book? what's your process for writing? where do you write? well, this one was a tough one. and i could not have done it without john nichols helped me. john is one of the great progressive writers in america. i started this book a few years ago and it was going pretty

point out that you are principally an investigator for separate obesity study, funded in part by eli lilly-changer in regards to a lot of some type two diabetes, we know it's hard for these types of patients to lose this type of, wait and the study has demonstrated significant weight loss in the populations. >> may lead to folks without diabetes getting some benefit. >> we've got a separate study, eli lately has been looking at is about to tide, for patients without tech to buy diabetes, and they actually lost more weight. so it's promising for both populations. >> one of the side effects? >> side effects have to do with the mechanism, because these are medications that look just like hormones that are made in our got, they cause got related side effects such as nausea, vomiting diarrhea, but overall the benefits are much greater than those risks. as reading about the trial obviously not having your expertise if i'm right the placebo group also lost weight. >> so that's something to be said for the benefit of diet, exercise, and behaviors. when we look at the trials, were seen right lots o

in a personal communication to dong xiaoping my views on this talk to the ambassador last night jim lilly. we've been in he's been in touch constantly with the chinese officials and so i can't i can't i don't feel that we've waited long when you have a force of this nature and you have events of this nature unfolding. we are the united states and they are china and what i want to do is continue to urge them. freedom democracy respect non-violence and with great admiration in my heart for the students so i don't think we've waited long. what was the other part of your question? yes, they did. they finally moved in. what do you think is we were urging on that's if i'm glad you raise that point we were and have been and will continue to urge restraint and they did the army did show restraint when one lee was here. he told me and this is very chinese the way he expressed it the army and they showed restraint for a long time and i don't i don't think i can't begin to fathom for you exactly what led to the to the order to use force because even as recently as a couple of days ago there were the

eli lilly, there's been a problem on valuation for five, six years. they continue to grow into it.en, was a $68 stock i think it closed at 113 today amgen, the best stock out there, that's way too cheap in this environment, so, though it's perceived to be safety, i actually think it's still investable as growth names, too. >> yeah, courtney, you look this as a defensive play? >> yeah, i do. our acronyms at the beginning of the year, united health and merck. those are two of the top holdings in there. and people were pessimistic on these after there was so much optimism last year and people started to rotate out of that trade. i think the fundamentals continue to look really strong and i think -- i don't think they're overvalued here, to guy's point, and i think they are going to continue to do well especially those two names, united health and merck, they have done a lot to reduce their costs. you had merck spun off some of their lower margin businesses, which is going to save them a billion and a half by next year. and you have united health, going to help their highest growth mar

green grain is integral parts with the revised food to nations in need tick lilly in africa where some countries are even struggling with famine. but some sources say the grain has not being reaching the intended recipient with only a fraction going to africa and almost half of it going to europe. as was now alive to as architecture, virtual conference and meetings found or at african villages offered thanks for joining us. today on this lovely we can here. now look to hear says about 14 percent or around 40 percent of the crane grain had, will said, so african nations. meanwhile, eastern europeans seem to have changed their tune if like saying they don't want or need the ukrainian grain any more. why, why do you think, why did they just send it to africa the 1st place like they were supposed to? well, luckily for you having me in this program and printed a gosh from the sunny john as well. one of the reasons that it's in immediately coming in the mind is the fact that we need to remind ourselves of this rule. it's not only about a guest or we didn't, you came it's, i guess europe as w

lilli: it just feels wrong. concern of his getting outcome of anybody getting out, that they will do it again. stephanie: do you know the perspective -- recidivism rate of those s >> i don't know. stephanie: the doj has found a study that the child molesters have the highest recidivism rate. does that change your answer? >> look, stephanie, that does not change my mind. what is the difference if we have someone who commits a crime that is a non-immigrant, and we have someone who is an immigrant? how is the community safer? stephanie: the question was, how can you make that assumption, that it is safer, without knowing the recidivism rate of convicted criticism -- criminals in san mateo county seeking asylum? >> you heard what i said, though, right? stephanie: my question was to you -- >> i hear you. sorry. stephanie: how could you know that without knowing the recidivism rate? >> i understand what you are saying. i get it. maybe safer, you know, let me walk that back. stephanie: the supervisor says he has heard

it is not yet approved to treat obesity, but drugmaker eli lilly is pushing for fda approval for thataughlin spoke with one study participant who said this drug changed her life. >> reporter: for almost a year, jennifer huber to be taking the drug to treat her type 2 diabetes. >> i get emotional. i'm down about 60 pounds, which that was not part of the plan. >> reporter: did this drug change your life? >> it changed my life. even though i'm a smaller person now, i feel that i'm more physical. >> lots to discuss with nbc medical contributor dr. vin gupta. eli lilly says their study shows participants lost nearly 16% of their weight over an 18-month trial. i think a lot of people are look at this and maybe thinking, is this too good to be true. >> well, ana, moments like this, thank you for having me, highlighting this important topic, this is a transformational moment for public health and medicine more broadly. rarely do we have moments where we can change the course of a chronic epidemic, like the obesity epidemic. 40% of american adults qualify as being obese based on the current gu